Andrew T Drechsler Baudax Bio, Inc. (BXRX) insider trading activity

BXRX Quotes by TradingView

Andrew T Drechsler is Director of Baudax Bio, Inc.. Currently has a direct ownership of 41,656 shares of BXRX, which is worth approximately $416. The most recent transaction as insider was on Jun 15, 2022, when has been sold 39,473 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 41.7K
0% 3M change
0% 12M change
Total Value Held $416

Andrew T Drechsler Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 15 2022
BUY
Grant, award, or other acquisition
-
39,473 Added 48.65%
41,656 Common Stock
Apr 07 2021
BUY
Grant, award, or other acquisition
-
56,452 Added 42.48%
76,452 Common Stock

Also insider at

PRVB
Provention Bio, Inc. Healthcare
Chief Financial Officer
ATD

Andrew T Drechsler

Director
Malvern, PA

Track Institutional and Insider Activities on BXRX

Follow Baudax Bio, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BXRX shares.

Notify only if

Insider Trading

Get notified when an Baudax Bio, Inc. insider buys or sells BXRX shares.

Notify only if

News

Receive news related to Baudax Bio, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on BXRX